Accorda Therapeutics has two big things going for it piquing my interest.
First, a nice long term chart is shaping up here. It's based for the better part of 7 years now with a base range from 18-40. It's recently formed a falling wedge pattern over the previous 6-7 months after testing all time highs this spring. A break above the wedge sets this thing up nicely for a test of all time highs and potentially a monster run to the 60's and beyond.
Accorda has a real interesting and deep product pipeline. They have three potentially real powerful drugs here that could multiply their market cap. Check out this video of the company's founder Ron Cohen and his recent appeared on Mad Money
12/9/13 update: nothing has taken place that changes our view, but this needs more time.
No comments:
Post a Comment